GH-axis peptide research
CJC-1295 (no DAC) + Ipamorelin
GHRH analog + selective GH secretagogue (research blend)
Coming soon· check back for availability
| Form | Lyophilized powder |
|---|---|
| Purity | Coming soon |
| Storage | −20 °C, protect from light |
| Use | Laboratory research only |
Coming soon
Ask about availability
For laboratory research use only. Not for human or veterinary use. Not a drug, supplement, or cosmetic. No dosing, administration, or use guidance is provided.
About this compound
Identity & research context
A research blend of two growth-hormone-axis peptides: CJC-1295 without DAC (a modified GRF(1-29) GHRH analog) and Ipamorelin (a selective growth-hormone secretagogue, or GHRP). In preclinical and in-vitro systems the pair has been studied as tool compounds for GHRH-receptor and GHS-R (ghrelin-receptor) signaling.
Key research points
- GHRH-receptor signaling — CJC-1295 / mod GRF(1-29) (in-vitro)
- GHS-R (ghrelin-receptor) agonism — Ipamorelin (in-vitro)
- GH-axis pulsatility research (animal models)
- Receptor-selectivity & secretagogue research (preclinical)
Published preclinical literature available on request. Specs and certificate details will be listed when this blend goes live.
For research purposes only. Not FDA approved. Information shown is sourced from published peer-reviewed literature for educational reference only — not medical advice or product claims. Read the full disclaimer.
Also in the catalog
View all